EUPRAXIA PHARMACEUTICALS INC. Depreciation Excluding Lessor Asset Under Operating Lease
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Depreciation Excluding Lessor Asset Under Operating Lease of $164.40 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DepreciationExcludingLessorAssetUnderOperatingLease · last filed 2026-03-13
| Period end | Depreciation Excluding Lessor Asset Under Operating Lease 12 month |
|---|---|
| 2025-12-31 | $164.40K 40-F · filed 2026-03-13 |
| 2024-12-31 | $114.03K 40-F · filed 2026-03-13 |
| 2023-12-31 | $112.88K 40-F · filed 2025-03-20 |
| 2022-12-31 | $110.10K 40-F · filed 2024-04-01 |